Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure.

Knowledge about the role of the right ventricle in health and disease historically has lagged behind that of the left ventricle. Less muscular, restricted in its role to pumping blood through a single organ, and less frequently or obviously involved than the left ventricle in diseases of epidemic proportions such as myocardial ischemia, cardiomyopathy, or valvulopathy, the right ventricle has generally been considered a mere bystander, a victim of pathological processes affecting the cardiovascular system. Consequently, comparatively little attention has been devoted to how right ventricular dysfunction may be best detected and measured, what specific molecular and cellular mechanisms contribute to maintenance or failure of normal right ventricular function, how right ventricular dysfunction evolves structurally and functionally, or what interventions might best preserve right ventricular function. Nevertheless, even the proportionately limited information related to right ventricular function, its impairment in various disease states, and its impact on the outcome of those diseases suggests that the right ventricle is an important contributor and that further understanding of these issues is of pivotal importance. For this reason, the National Heart, Lung, and Blood Institute convened a working group charged with delineating in broad terms the current base of scientific and medical understanding about the right ventricle and identifying avenues of investigation likely to meaningfully advance knowledge in a clinically useful direction. The following summary represents the presentations and discussions of this working group. The right ventricle is affected by and contributes to a number of disease processes, including perhaps most notably pulmonary hypertension caused by a variety of lung or pulmonary vascular diseases (cor pulmonale). Other diseases affect the right ventricle in different ways, including global, left ventricular–, or right ventricular–specific cardiomyopathy; right ventricular ischemia or infarction; pulmonary or tricuspid valvular heart disease; and left-to-right shunts. The right ventricle pumps the same …

[1]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[2]  D. Cokkinos,et al.  Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. , 1998, The American journal of cardiology.

[3]  R. Quaife,et al.  The pressure-overloaded right ventricle in pulmonary hypertension. , 1998, Chest.

[4]  B. Groves,et al.  Importance of right ventricular end-systolic regional wall stress in idiopathic pulmonary arterial hypertension: a new method for estimation of right ventricular wall stress. , 2006, European journal of medical research.

[5]  E. Trulock,et al.  Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  P. Pruszczyk N-terminal pro-brain natriuretic peptide as an indicator of right ventricular dysfunction. , 2005, Journal of cardiac failure.

[7]  R. Barst,et al.  Survival with first-line bosentan in patients with primary pulmonary hypertension , 2005, European Respiratory Journal.

[8]  L. Tavazzi,et al.  Five-minute recording of heart rate variability in severe chronic heart failure: correlates with right ventricular function and prognostic implications. , 2000, American heart journal.

[9]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[10]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[11]  J. Dupuis,et al.  Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. , 2003, Cardiovascular research.

[12]  M. Mcgoon,et al.  Diagnostic Dilemmas: Diastolic Heart Failure Causing Pulmonary Hypertension and Pulmonary Hypertension Causing Diastolic Dysfunction , 2006 .

[13]  M. Hoeper,et al.  Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. , 2001, Chest.

[14]  N. Danchin,et al.  Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. , 1997, European heart journal.

[15]  D. Srivastava,et al.  The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner , 2004, Development.

[16]  M. Barančík,et al.  Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. , 2006, General physiology and biophysics.

[17]  G. Montalescot,et al.  Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. , 1998, The American journal of cardiology.

[18]  M. Beckerle,et al.  Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt. , 2005, The Journal of clinical investigation.

[19]  M. Mehra,et al.  Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension. , 2004, Congestive heart failure.

[20]  J. Sandoval,et al.  Survival in primary pulmonary hypertension. Validation of a prognostic equation. , 1994, Circulation.

[21]  T. Bashore,et al.  The forgotten chamber: the importance of the right ventricle. , 1995, Catheterization and cardiovascular diagnosis.

[22]  Jayant Nath,et al.  Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.

[23]  A. Taylor,et al.  Evolution of resting lung function in the first year after cardiac transplantation. , 1995, The European respiratory journal.

[24]  J. Schaper,et al.  The role of cell death in heart failure. , 1999, Circulation research.

[25]  W. Hopkins The remarkable right ventricle of patients with Eisenmenger syndrome , 2005, Coronary artery disease.

[26]  L. La Vecchia,et al.  Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy. , 1999, The American journal of cardiology.

[27]  R. Favaloro,et al.  Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[28]  A. Torbicki,et al.  Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension , 2003, Circulation.

[29]  A J Tajik,et al.  Doppler echocardiographic index for assessment of global right ventricular function. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  K. Chin,et al.  The right ventricle in pulmonary hypertension , 2005, Coronary artery disease.

[31]  L. Dušek,et al.  Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. , 2003, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[32]  R. Levine,et al.  Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. , 1998, The American journal of cardiology.

[33]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[34]  L. Tavazzi,et al.  Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 2000, The American journal of cardiology.

[35]  J. Polak,et al.  Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. , 1983, Journal of the American College of Cardiology.

[36]  J. Lewis,et al.  Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: recognition and clinical implications. , 1993, Journal of the American College of Cardiology.

[37]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[38]  L. Leinwand,et al.  Soy diet worsens heart disease in mice. , 2005, The Journal of clinical investigation.

[39]  J. Bronzwaer,et al.  Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. , 2004, Chest.

[40]  M. Wilén,et al.  Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. , 1984, The American journal of cardiology.

[41]  J. Thomas,et al.  Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. , 1997, The American journal of cardiology.

[42]  D. Green,et al.  Suicidal Tendencies: Apoptotic Cell Death by Caspase Family Proteinases* , 1999, The Journal of Biological Chemistry.

[43]  M. Cleman,et al.  The right ventricle in disorders causing pulmonary venous hypertension. , 1992, Cardiology clinics.

[44]  J. Mandel Chapter 6 – Approach to the Patient With Pulmonary Hypertension , 2006 .

[45]  V. Aiello,et al.  Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. , 2002, The Journal of thoracic and cardiovascular surgery.

[46]  B. Conne,et al.  Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. , 1990, The American journal of pathology.

[47]  A. Torbicki,et al.  Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. , 2003, Journal of the American College of Cardiology.

[48]  C. Gross,et al.  Pulmonary function after successful heart transplantation. One year follow-up. , 1993, Chest.

[49]  H. Bittner,et al.  Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. , 1998, Circulation.

[50]  E. Trulock,et al.  Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. , 1991, Journal of the American College of Cardiology.

[51]  W. Pu,et al.  Morphogenesis of the right ventricle requires myocardial expression of Gata4. , 2005, The Journal of clinical investigation.

[52]  M. Cutolo,et al.  Successful management of neonatal cryoglobulinaemia after a gemellar pregnancy in a woman with symptomatic type I cryoglobulinaemia , 2004, Annals of the Rheumatic Diseases.

[53]  M. B. Perryman,et al.  Importance of angiotensin-converting enzyme in pulmonary hypertension. , 1995, Cardiology.

[54]  M. Mathier,et al.  Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. , 1995, Journal of the American College of Cardiology.

[55]  S. R. Cohen,et al.  Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. , 1985, Journal of the American College of Cardiology.

[56]  D. Berman,et al.  Variable spectrum and prognostic implications of left and right ventricular ejection fractions in patients with and without clinical heart failure after acute myocardial infarction. , 1986, The American journal of cardiology.

[57]  B. Groves,et al.  Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.

[58]  M. Vogeser,et al.  Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[59]  A. Waggoner,et al.  Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. , 2002, The American journal of cardiology.

[60]  J. Guerrero,et al.  Myocardial perfusion and right ventricular function. , 1999, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[61]  K. Kangawa,et al.  Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. , 2000, Circulation.

[62]  B. Gehlbach,et al.  The pulmonary manifestations of left heart failure. , 2004, Chest.

[63]  E. Dodou,et al.  The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. , 2005, Developmental biology.

[64]  L. Boxt,et al.  Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. , 1992, Journal of the American College of Cardiology.

[65]  M. Guazzi,et al.  Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. , 2000, Journal of the American College of Cardiology.

[66]  C Berzuini,et al.  Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[67]  P. Krieg,et al.  Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. , 2003, Developmental biology.

[68]  B. Brundage,et al.  Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. , 1995, Circulation.

[69]  L. Yap B-Type Natriuretic Peptide and the Right Heart , 2004, Heart Failure Reviews.

[70]  J. Gorcsan,et al.  Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome. , 1996, Circulation.

[71]  I. Palacios,et al.  Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. , 1994, American heart journal.

[72]  A. Frans,et al.  Lung membrane diffusing capacity, heart failure, and heart transplantation. , 1999, The American journal of cardiology.

[73]  L. Tavazzi,et al.  Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. , 2003, American heart journal.

[74]  B Wranne,et al.  Normal regional right ventricular function and its change with age: a Doppler myocardial imaging study. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[75]  C. R. Smith,et al.  Variability of right ventricular functional recovery after lung transplantation. , 1996, Transplantation.

[76]  A. Baker,et al.  Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. , 2006, American journal of physiology. Heart and circulatory physiology.

[77]  J. Seward,et al.  Relation of tissue displacement and strain to invasively determined right ventricular stroke volume. , 2005, The American journal of cardiology.

[78]  W. Kuebler,et al.  The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo , 2003, Intensive Care Medicine.

[79]  D. Srivastava,et al.  The bHLH factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sidedness. , 1998, Developmental biology.

[80]  Ladislav Dusek,et al.  Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[81]  J. Molkentin,et al.  Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene , 1994, Molecular and cellular biology.

[82]  I. Dimopoulou,et al.  Effects of severity of long-standing congestive heart failure on pulmonary function. , 1998, Respiratory medicine.

[83]  M. Buckingham,et al.  Right Ventricular Myocardium Derives From the Anterior Heart Field , 2004, Circulation research.

[84]  C. Greyson,et al.  Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload. , 2000, American journal of physiology. Heart and circulatory physiology.

[85]  B. Groves,et al.  Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics , 2003, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[86]  X Marchandise,et al.  Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. , 1998, Journal of the American College of Cardiology.

[87]  John McAnally,et al.  BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart , 2005, Development.

[88]  K. Maehara,et al.  Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. , 1998, Circulation.

[89]  I. Starr,et al.  The absence of conspicuous increments of venous pressure after severe damage to the right ventricle of the dog, with a discussion of the relation between clinical congestive failure and heart disease , 1943 .

[90]  A. Harmar,et al.  Interdependent Serotonin Transporter and Receptor Pathways Regulate S100A4/Mts1, a Gene Associated With Pulmonary Vascular Disease , 2005, Circulation research.

[91]  R. Bansal,et al.  Determinants of the rate of right ventricular pressure rise by Doppler echocardiography: potential value in the assessment of right ventricular function. , 1994, The Journal of heart valve disease.

[92]  D. Mccrory,et al.  Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.